Dipalmitoleoylphosphoethanolamine as a PP2A Enhancer Obstructs Insulin Signaling by Promoting Ser/Thr Dephosphorylation of Akt

Cellular Physiology and Biochemistry

Volumn 34, Issue 3, 2014, Pages 617-627

  Tsuchiya, Ayako ^a   Kanno, Takeshi ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Akt; Glucose uptake; GLUT4; Phosphatidylethanolamine; Protein phosphatase 2A

Indexed keywords

1,2 DIARACHIDONOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 1,2 DILINOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 1,2 DIOLEOYL SN GLYCERO PHOSPHOTHANOLAMINE; 1,2 DIPALMITOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; DIPALMITOLEOYLPHOSPHOETHANOLAMINE; GLUCOSE TRANSPORTER 4; INSULIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; DIPALMITOLEOYLPHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE DERIVATIVE; PHOSPHOPROTEIN PHOSPHATASE 2; SERINE; THREONINE; UNSATURATED FATTY ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; 3T3 CELL LINE; ANIMAL; ENZYME ACTIVATION; METABOLISM; MOUSE; PHOSPHORYLATION;

3T3-L1 CELLS; ANIMALS; ENZYME ACTIVATION; ETHANOLAMINES; FATTY ACIDS, UNSATURATED; HUMANS; INSULIN; MICE; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT; SERINE; SIGNAL TRANSDUCTION; THREONINE;

EID: 84906609299     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363027     Document Type: Article

References (24)

1. Obanda DN, Cefalu WT: Modulation of cellular insulin signaling and PTP1B effects by lipid metabolites in skeletal muscle cells. J Nutr Biochem 2013;24:1529-1537.
2. Obanda DN, Hernandez A, Ribnicky D, Yu Y, Zhang XH, Wang ZQ, Cefalu WT: Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells. Diabetes 2012;61:597-605.
3. Feng XT, Wang TZ, Leng J, Chen Y, Liu JB, Liu Y, Wang WJ: Palmitate contributes to insulin resistance through downregulation of the Src-mediated phosphorylation of Akt in C2C12 myotubes. Biosci Biotechnol Biochem 2012;76:1356-1361.
4. Kanno T, Tsuchiya A, Shimizu T, Tanaka A, Nishizaki T: Indomethacin serves as a potential inhibitor of protein phosphatases. Cell Physiol Biochem 2012;30:1014-1022.
5. Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY, Chiang CW: Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55a regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 2008;283:1882-1892.
6. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS: AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002;277:23977-23980.
7. Reynolds TH4th, Bodine SC, Lawrence JCJr: Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 2002;277:17657-17662.
8. Sekulić A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT: A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogenstimulated and transformed cells. Cancer Res 2000;60:3504-3513.
9. Withers DJ, Ouwens DM, Nave BT, van der Zon GC, Alarcon CM, Cardenas ME, Heitman J, Maassen JA, Shepherd PR: Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. Biochem Biophys Res Commun 1997;241:704-709.
10. Bayascas JR, Alessi DR: Regulation of Akt/PKB Ser473 phosphorylation. Mol Cell 2005;18:143-145.
11. Gao T, Furnari F, Newton AC: PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 2005;18:13-24.
12. Shibata E, Kanno T, Tsuchiya A, Kuribayashi K, Tabata C, Nakano T, Nishizaki T: Free fatty acids inhibit protein tyrosine phosphatase 1B and activate Akt. Cell Physiol Biochem 2013;32:871-879.
13. Ferrari S, Pearson RB, Siegmann M, Kozma SC, and Thomas G: The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites. J Biol Chem 1993;268:16091-16094.
14. Martin TD, Dennis MD, Gordon BS, Kimball SR, Jefferson LS: mTORC1 and JNK coordinate phosphorylation of the p70S6K1 autoinhibitory domain in skeletal muscle following functional overloading. Am J Physiol Endocrinol Metab 2014;306:E1397-405.
15. Guo S: Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol 2014;220:T1-T23.
16. Taniguchi CM, Emanuelli B, Kahn CR: Critical nodes in signaling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006;7:85-96.
17. Deeba F, Tahseen HN, Sharad KS, Ahmad N, Akhtar S, Saleemuddin M, Mohammad O: Phospholipid diversity: Correlation with membrane-membrane fusion events. Biochim Biophys Acta 2005;1669:170-181.
18. Emoto K, Kobayashi T, Yamaji A, Aizawa H, Yahara I, Inoue K, Umeda M: Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc Natl Acad Sci USA 1996;93:12867-12872.
19. Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, Mizushima N, Tanida I, Kominami E, Ohsumi M, Noda T, Ohsumi Y: A ubiquitin-like system mediates protein lipidation. Nature 2000;408:488-492.
20. Emoto K, Toyama-Sorimachi N, Karasuyama H, Inoue K, Umeda M: Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell Res 1997;232:430-434.
21. Yaguchi T, Nagata T, Nishizaki T: 1,2-dilinoleoyl-sn-glycero-3-phosphoethanolamine ameliorates agerelated spatial memory deterioration by preventing neuronal cell death. Behav Brain Funct 2010;6:52. doi:10.1186/1744-9081-6-52.
22. Pavlovic Z, Bakovic M: Regulation of phosphatidylethanolamine homeostasis-The critical role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2). Int J Mol Sci 2013;14:2529-2550.
23. Fullerton MD, Hakimuddin F, Bonen A, Bakovic M: The development of a metabolic disease phenotype in CTP: Phosphoethanolamine cytidylyltransferase-deficient mice. J Biol Chem 2009;284:25704-25713.
24. Singh RK, Fullerton MD, Vine D, Bakovic M: Mechanism of hypertriglyceridemia in CTP: phosphoethanolamine cytidylyltransferase-deficient mice. J Lipid Res 2012;53:1811-1822.